1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity

被引：61

作者：

Hale, JJ ^{[1
]}

Budhu, RJ

Holson, EB

Finke, PE

Oates, B

Mills, SG

MacCoss, M

Gould, SL

DeMartino, JA

Springer, MS

Siciliano, S

Malkowitz, L

Schleif, WA

Hazuda, D

Miller, M

Kessler, J

Danzeisen, R

Holmes, K

Lineberger, J

Carella, A

Carver, G

Emini, E

机构：

[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA

[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA

[3] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 20期

关键词：

D O I：

10.1016/S0960-894X(01)00545-5

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Investigations of the structure-activity relationships of 1,3,4-trisubstituted pyrrolidine human CCR5 receptor antagonists afforded orally bioavailable compounds with the ability to inhibit HIV replication in vitro. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：2741 / 2745

页数：5

共 14 条

[1] A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M
Nishimura, O
Kanzaki, N
Okamoto, M
Sawada, H
Iizawa, Y
Shiraishi, M
Aramaki, Y
Okonogi, K
Ogawa, Y
Meguro, K
Fujino, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5698 - 5703
[2] Baroudy B. M., 2000, 7 C RETR OPP INF SAN
[3] HIV-1 entry - an expanding portal for drug discovery
Blair, WS
Lin, PF
Meanwell, NA
Wallace, OB
[J]. DRUG DISCOVERY TODAY, 2000, 5 (05) : 183 - 194
[4] CALDWELL CG, 2000, ACS 220 NAT M WASH D
[5] Identification of a major co-receptor for primary isolates of HIV-1
Deng, HK
Liu, R
Ellmeier, W
Choe, S
Unutmaz, D
Burkhart, M
DiMarzio, P
Marmon, S
Sutton, RE
Hill, CM
Davis, CB
Peiper, SC
Schall, TJ
Littman, DR
Landau, NR
[J]. NATURE, 1996, 381 (6584) : 661 - 666
[6] Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes
Dorn, CP
Finke, PE
Oates, B
Budhu, RJ
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) : 259 - 264
[7] HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T
Litwin, V
Allaway, GP
Martin, SR
Huang, YX
Nagashima, KA
Cayanan, C
Maddon, PJ
Koup, RA
Moore, JP
Paxton, WA
[J]. NATURE, 1996, 381 (6584) : 667 - 673
[8] Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes
Finke, PE
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2475 - 2479
[9] Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes
Finke, PE
Meurer, LC
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) : 265 - 270
[10] 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements
Hale, JJ
Budhu, RJ
Mills, SG
MacCoss, M
Malkowitz, L
Siciliano, S
Gould, SL
DeMartino, JA
Springer, MS
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1437 - 1440

← 1 2 →